|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 112, Issue 12 1855-1864, Copyright © 1999 by Company of Biologists
JOURNAL ARTICLES |
JF Talts, G Wirl, M Dictor, WJ Muller and R Fassler
Max-Planck-Institute of Biochemistry, Department of Protein Chemistry, Germany.
The local growth of tumors and their ability to metastasize are crucially dependent on their interactions with the surrounding extracellular matrix. Tenascin-C (TNC) is an extracellular matrix protein which is highly expressed during development, tissue repair and cancer. Despite the high levels of TNC in the stroma of primary and metastatic tumors, the function of TNC is not known. In the present study we have crossed TNC-null mice with a mouse strain where both female and male mice spontaneously develop mammary tumors followed by metastatic disease in the lungs. We report that the absence of TNC had no effect on the temporal occurrence of mammary tumors and their metastatic dissemination in lungs. Furthermore, the number and size of tumors, the number and size of metastatic foci in the lungs, the proliferation rate and apoptosis of tumor cells and tumor angiogenesis were not altered in the absence of TNC. Histological examination revealed that the tumor organisation, however, was modulated by TNC. In the presence of TNC both primary as well as metastatic tumors were organised in large tumor cell nests surrounded by thick layers of extracellular matrix proteins. In the absence of TNC these tumor cell nests were smaller but still separated from each other by extracellular matrix proteins. In addition, the TNC-null stromal compartment contained significantly more monocytes/macrophages than tumor stroma from TNC wild-type mice. Using in vitro coculture experiments we show that TNC-null tumor cells were still able to activate the TNC gene in fibroblasts which express low basal levels of TNC. Altogether these data indicate that TNC has a very limited role during the spontaneous development and growth of mamary tumors and their metastasis to the lungs.
This article has been cited by other articles:
![]() |
M. Galie, C. Sorrentino, M. Montani, L. Micossi, E. Di Carlo, T. D'Antuono, L. Calderan, P. Marzola, D. Benati, F. Merigo, et al. Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells Carcinogenesis, November 1, 2005; 26(11): 1868 - 1878. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamamoto, K. Onoda, Y. Sawada, K. Fujinaga, K. Imanaka-Yoshida, H. Shimpo, T. Yoshida, and I. Yada Tenascin-C is an essential factor for neointimal hyperplasia after aortotomy in mice Cardiovasc Res, February 15, 2005; 65(3): 737 - 742. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Roth-Kleiner, E. Hirsch, and J. C. Schittny Fetal Lungs of Tenascin-C-Deficient Mice Grow Well, but Branch Poorly in Organ Culture Am. J. Respir. Cell Mol. Biol., March 1, 2004; 30(3): 360 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fluck, M. Chiquet, S. Schmutz, M.-H. Mayet-Sornay, and D. Desplanches Reloading of atrophied rat soleus muscle induces tenascin-C expression around damaged muscle fibers Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2003; 284(3): R792 - R801. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Huang, R. Chiquet-Ehrismann, J. V. Moyano, A. Garcia-Pardo, and G. Orend Interference of Tenascin-C with Syndecan-4 Binding to Fibronectin Blocks Cell Adhesion and Stimulates Tumor Cell Proliferation Cancer Res., December 1, 2001; 61(23): 8586 - 8594. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Loike, L. Cao, S. Budhu, S. Hoffman, and S. C. Silverstein Blockade of {{alpha}}5{{beta}}1 Integrins Reverses the Inhibitory Effect of Tenascin on Chemotaxis of Human Monocytes and Polymorphonuclear Leukocytes Through Three-Dimensional Gels of Extracellular Matrix Proteins J. Immunol., June 15, 2001; 166(12): 7534 - 7542. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Y. Lin, A. V. Nguyen, R. G. Russell, and J. W. Pollard Colony-stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy J. Exp. Med., March 19, 2001; 193(6): 727 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mackie and R. Tucker The tenascin-C knockout revisited J. Cell Sci., January 11, 1999; 112(22): 3847 - 3853. [Abstract] [PDF] |
||||